Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Correction to: Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
Publication Year: 2024 Source: Inflamm Bowel Dis PMID: 38676912
No Abstract
Investigating the concomitance of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitides and inflammatory bowel disease (IBD)
Publication Year: 2024 Source: Semin Arthritis Rheum PMID: 38677223 DOI: 10.1016/j.semarthrit.2024.152452
OBJECTIVE: To assess relationship between Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis and inflammatory bowel disease (IBD). METHODS: This is a retrospective study design. The patients were identified using a preset criteria of patients who have the diagnosis of ANCA associated vasculitis including a diagnosis of granulomatosis with polyangiitis (GPA) or …
Zhilining Formula alleviates DSS-induced colitis through suppressing inflammation and gut barrier dysfunction via the AHR/NF-κBp65 axis
Publication Year: 2024 Source: Phytomedicine PMID: 38677270
No Abstract
Higher Dietary Quercetin Intake Is Associated with Lower Risk of Adverse Outcomes among Individuals with Inflammatory Bowel Disease in a Prospective Cohort Study
Publication Year: 2024 Source: J Nutr PMID: 38677479 DOI: 10.1016/j.tjnut.2024.04.025
BACKGROUND: Cumulative preclinical evidence reported quercetin, a major flavonoid, can attenuate the disease activity of inflammatory bowel diseases (IBD). However, there is limited evidence that supports the benefits of quercetin for patients with IBD. OBJECTIVES: To investigate whether dietary quercetin intake is associated with adverse outcomes among individuals with IBD …
Basket, Umbrella, and Platform Trials: The Potential for Master Protocol-Based Trials in Inflammatory Bowel Disease
Publication Year: 2024 Source: Gastroenterology PMID: 38677483 DOI: 10.1053/j.gastro.2024.04.020
No Abstract
A Curious Case of Colitis
Publication Year: 2024 Source: Gastroenterology PMID: 38677484
No Abstract
Tracking the therapeutic efficacy of a ketone mono ester and β-hydroxybutyrate for ulcerative colitis in rats: New perspectives
Publication Year: 2024 Source: Toxicol Appl Pharmacol PMID: 38677600
No Abstract
Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches
Publication Year: 2024 Source: Benef Microbes PMID: 38677716
No Abstract
Colorectal Disease and the Gut Microbiome: What a Surgeon Needs to Know
Publication Year: 2024 Source: Surg Clin North Am PMID: 38677827
The gut microbiome is defined as the microorganisms that reside within the gastrointestinal tract and produce a variety of metabolites that impact human health. These microbes play an intricate role in human health, and an imbalance in the gut microbiome, termed gut dysbiosis, has been implicated in the development of …
Medical Management of Inflammatory Bowel Disease
Publication Year: 2024 Source: Surg Clin North Am PMID: 38677828
No Abstract
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide